retatrutide weight loss clinical trials results Results: 28.3% Data Retatrutide NEW Phase 3 Clinical

A recent head-to-head clinical trial comparing Wegovy and Zepbound returned similar results

I think really on three sides on the R&D and research side, because that is incredibly capital intensive

However, these are generally not a concern with typical consumption levels

Lancet 402(10401):529544 [DOI] [PubMed] [Google Scholar] 29.Papageorgiou M, Biver E (2023) Bone consequences of intentional weight loss in overweight or obese patients

Retatrutide is in Phase 3 clinical trials traditionally one of the final steps before the FDA reviews and potentially approves a drug

It means the providers, the protocols, and the support structure are all designed specifically for this type of treatment